EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitLeitlinieOpen Access · CC BY-NC-ND 4.0

Innovative cellular therapies for autoimmune diseases: expert-based position statement and clinical practice recommendations from the EBMT practice harmonization and guidelines committee

Raffaella Greco, Tobias Alexander, Nicoletta Del Papa, Fabian Müller, Riccardo Saccardi, Fermin Sanchez-Guijo, Georg Schett, Basil Sharrack, John A Snowden, Karin Tarte, Francesco Onida, Isabel Sánchez-Ortega und 14 weitere

eClinicalMedicine · 2024-03 · 69 · 102476

DOI: 10.1016/j.eclinm.2024.102476 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift eClinicalMedicine, 2024-03. Verfasst von Raffaella Greco und 25 weiteren Autor:innen. Beteiligte Einrichtung: Unit of Hematology and Bone Marrow Transplantation, IRCCS San Raffaele Hospital, Vita-Salute San Raffaele University, Milan, Italy. Die Arbeit wurde bisher 100-mal zitiert (Crossref) und nennt 86 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Autoimmune diseases (ADs) are characterized by loss of immune tolerance, high chronicity, with substantial morbidity and mortality, despite conventional immunosuppression (IS) or targeted disease modifying therapies (DMTs), which usually require repeated administration. Recently, novel cellular therapies (CT), including mesenchymal stromal cells (MSC), Chimeric Antigen Receptors T cells (CART) and regulatory T cells (Tregs), have been successfully adopted in ADs. An international expert panel of the European Society for Blood and Marrow Transplantation and the International Society for the Cell and Gene Therapy, reviewed all available evidence, based on the current literature and expert practices, on use of MSC, CART and Tregs, in AD patients with rheumatological, neurological, and gastroenterological indications. Expert-based consensus and recommendations for best practice and quality of patient care were developed to support clinicians, scientists, and their multidisciplinary teams, as well as patients and care providers and will be regularly updated.

Schlagwörter

Stichwörter der Autor:innen

Autoimmune diseasesChimeric antigen receptor (CAR) T cellsMesenchymal stem cellsRegulatory T cells

Autor:innen und Institutionen

  • Unit of Hematology and Bone Marrow Transplantation, IRCCS San Raffaele Hospital, Vita-Salute San Raffaele University, Milan, Italy.
  • Co-Chair of the Practice Harmonization and Guidelines Committee of EBMT and Chair of the ADWP of the EBMT, Barcelona, Spain.
  • Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin Institute of Health, Department of Rheumatology and Clinical Immunology, Berlin, Germany.
  • Scleroderma Clinic, Rheumatology Department, ASST G. Pini-CTO, Università degli Studi di Milano, Milano, Italy.
  • Department of Internal Medicine 5 - Hematology and Oncology, University Hospital of Erlangen, Erlangen, Germany.
  • Bayrisches Zentrum für Krebsforschung (BZKF) Erlangen, Germany.

Zitieren

APA

Greco, R., Alexander, T., Del Papa, N., Müller, F., Saccardi, R., Sanchez-Guijo, F., Schett, G., Sharrack, B., Snowden, J. A., Tarte, K., Onida, F., Sánchez-Ortega, I., Burman, J., Castilla Llorente, C., Cervera, R., Ciceri, F., Doria, A., Henes, J., Lindsay, J., …, & Farge, D. (2024). Innovative cellular therapies for autoimmune diseases: expert-based position statement and clinical practice recommendations from the EBMT practice harmonization and guidelines committee. eClinicalMedicine, 69, 102476. https://doi.org/10.1016/j.eclinm.2024.102476

Vancouver

Greco R, Alexander T, Del Papa N, Müller F, Saccardi R, Sanchez-Guijo F, et al. Innovative cellular therapies for autoimmune diseases: expert-based position statement and clinical practice recommendations from the EBMT practice harmonization and guidelines committee. eClinicalMedicine. 2024;69:102476. doi:10.1016/j.eclinm.2024.102476

BibTeX
@article{Greco2024,
  author = {Greco, Raffaella and Alexander, Tobias and Del Papa, Nicoletta and Müller, Fabian and Saccardi, Riccardo and Sanchez-Guijo, Fermin and Schett, Georg and Sharrack, Basil and Snowden, John A and Tarte, Karin and Onida, Francesco and Sánchez-Ortega, Isabel and Burman, Joachim and Castilla Llorente, Cristina and Cervera, Ricard and Ciceri, Fabio and Doria, Andrea and Henes, Jörg and Lindsay, James and Mackensen, Andreas and Muraro, Paolo A and Ricart, Elena and Rovira, Montserrat and Zuckerman, Tsila and Yakoub-Agha, Ibrahim and Farge, Dominique},
  title = {Innovative cellular therapies for autoimmune diseases: expert-based position statement and clinical practice recommendations from the EBMT practice harmonization and guidelines committee},
  journal = {eClinicalMedicine},
  year = {2024},
  volume = {69},
  pages = {102476},
  doi = {10.1016/j.eclinm.2024.102476}
}
Kostenlos starten →